Pet Pharm Biotech Co., Ltd. (TPEX:7762)

Pet Pharm Biotech Statistics

Total Valuation

TPEX:7762 has a market cap or net worth of TWD 3.71 billion. The enterprise value is 3.57 billion.

Market Cap	3.71B
Enterprise Value	3.57B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Aug 25, 2025

Share Statistics

TPEX:7762 has 50.53 million shares outstanding.

Current Share Class	50.53M
Shares Outstanding	50.53M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.42%
Owned by Institutions (%)	3.36%
Float	34.96M

Valuation Ratios

The trailing PE ratio is 203.89.

PE Ratio	203.89
Forward PE	n/a
PS Ratio	28.38
PB Ratio	6.37
P/TBV Ratio	6.47
P/FCF Ratio	n/a
P/OCF Ratio	128.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 128.83, with an EV/FCF ratio of -22.39.

EV / Earnings	246.19
EV / Sales	27.32
EV / EBITDA	128.83
EV / EBIT	n/a
EV / FCF	-22.39

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.08.

Current Ratio	3.16
Quick Ratio	1.54
Debt / Equity	0.08
Debt / EBITDA	1.58
Debt / FCF	-0.28
Interest Coverage	45.58

Financial Efficiency

Return on equity (ROE) is 2.91% and return on invested capital (ROIC) is 0.93%.

Return on Equity (ROE)	2.91%
Return on Assets (ROA)	0.81%
Return on Invested Capital (ROIC)	0.93%
Return on Capital Employed (ROCE)	1.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	4.96

Taxes

Income Tax	-2.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +124.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+124.81%
50-Day Moving Average	59.61
200-Day Moving Average	52.84
Relative Strength Index (RSI)	79.92
Average Volume (20 Days)	145,908

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7762 had revenue of TWD 130.70 million and earned 14.51 million in profits. Earnings per share was 0.36.

Revenue	130.70M
Gross Profit	69.96M
Operating Income	8.11M
Pretax Income	12.42M
Net Income	14.51M
EBITDA	27.72M
EBIT	8.11M
Earnings Per Share (EPS)	0.36

Balance Sheet

The company has 181.79 million in cash and 43.88 million in debt, giving a net cash position of 137.91 million or 2.73 per share.

Cash & Cash Equivalents	181.79M
Total Debt	43.88M
Net Cash	137.91M
Net Cash Per Share	2.73
Equity (Book Value)	582.54M
Book Value Per Share	14.46
Working Capital	301.88M

Cash Flow

In the last 12 months, operating cash flow was 28.88 million and capital expenditures -188.40 million, giving a free cash flow of -159.51 million.

Operating Cash Flow	28.88M
Capital Expenditures	-188.40M
Free Cash Flow	-159.51M
FCF Per Share	-3.16

Margins

Gross margin is 53.53%, with operating and profit margins of 6.21% and 11.10%.

Gross Margin	53.53%
Operating Margin	6.21%
Pretax Margin	9.50%
Profit Margin	11.10%
EBITDA Margin	21.21%
EBIT Margin	6.21%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.12%.

Dividend Per Share	0.09
Dividend Yield	0.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	55.42%
Buyback Yield	n/a
Shareholder Yield	0.12%
Earnings Yield	0.39%
FCF Yield	-4.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:7762 has an Altman Z-Score of 5.98 and a Piotroski F-Score of 4.

Altman Z-Score	5.98
Piotroski F-Score	4